High levels of infiltrating CD163+ tumor-associated macrophages are associated with a high risk of lymph node metastasis (26), while high levels of infiltrating CD206+ or CD68+ tumor-associated macrophages are associated with a better prognosis (43, 44). The gene discussed is MRC1; the disease is neoplasm.